FDA·Medicines·March 11, 2026

Harvard Drug Group recalls Midodrine Hydrochloride 5 mg tablets over poorly sealed blister packs

The blister packs of these prescription tablets were not sealed properly, so the container is defective.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Hazard
Defective container; inadequately sealed blister packaging.
Units
8892 cartons
Where sold
Nationwide US.
FDA classification
Class II · Ongoing
Classified by FDA
March 3, 2026
Recall started
February 17, 2026
FDA enforcement report
March 11, 2026
Identifiers
  • Codes: Lot # N02640, Exp Date: 08/2027
  • FDA recall number: D-0383-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
Reason for recall
Defective container; inadequately sealed blister packaging.
Classification
Class II (Ongoing)
Distribution
Nationwide US.
Quantity
8892 cartons

Related recalls